This paper is in the following e-collection/theme issue:

Reviews on Usage or other Formative Evaluation Metrics (34) Cost-Effectiveness and Economics (188) Implantable Drug Delivery Systems, Ingestible Sensors and Digital Pills (12) Gastroenterology and Hepatology (36)

Published on in Vol 5 , No 1 (2021) :January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13888, first published .
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Authors of this article:

Mattias Neyt 1 Author Orcid Image ;   Annick Christiaens 2 Author Orcid Image ;   Marina Aloi 3 Author Orcid Image ;   Lissy de Ridder 4 Author Orcid Image ;   Nicholas M Croft 5 Author Orcid Image ;   Sibylle Koletzko 6, 7 Author Orcid Image ;   Arie Levine 8 Author Orcid Image ;   Dan Turner 9 Author Orcid Image ;   Richard K Russell 10 Author Orcid Image ;   Frank M Ruemmele 11, 12 Author Orcid Image ;   Gigi Veereman 13 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.